Skip to Content

Obesity drug Wegovy is approved to cut heart attack and stroke risk in overweight patients

AP Health Writer

The popular weight-loss drug Wegovy can now be used to reduce the risk of stroke, heart attacks and other serious heart problems in patients who are overweight or who have obesity. The U.S. Food and Drug Administration approved a label change that expands the use of the drug in Wegovy. It was previously approved to treat obesity. The move is expected to change the way many heart patients are treated. The new indication also could broaden coverage of the drug by Medicare, which is prohibited from paying for weight-loss medications. The drug remains expensive and in short supply.

Article Topic Follows: AP-National

Jump to comments ↓

Associated Press


KVIA ABC 7 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content